The paper diagnostics market size has grown rapidly in recent years. It will grow from $10.49 billion in 2025 to $11.62 billion in 2026 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to growth in point-of-care testing demand, rising prevalence of infectious diseases, expansion of decentralized healthcare services, adoption of rapid screening tools, increased use of dipstick diagnostics.
The paper diagnostics market size is expected to see rapid growth in the next few years. It will grow to $17.31 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to increasing demand for home-based diagnostics, rising investments in affordable healthcare technologies, expansion of preventive healthcare screening, growing focus on early disease detection, advancements in paper microfluidics technology. Major trends in the forecast period include increasing adoption of rapid point-of-care paper tests, rising demand for low-cost diagnostic solutions, growing use of lateral flow assays, expansion of paper-based microfluidic devices, enhanced focus on disposable and eco-friendly diagnostics.
The rising prevalence of heart diseases is anticipated to drive growth in the paper diagnostics market in the future. Heart disease refers to any condition that affects the cardiovascular system. A sensitive and rapid microfluidic paper-based device (PAD) enables the simultaneous detection of multiple cardiac biomarkers for the early and late diagnosis of acute myocardial infarction. Consequently, the growing incidence of heart diseases is increasing the demand for paper diagnostics. For example, in September 2024, data published by the British Heart Foundation, a UK-based cardiovascular research charity, revealed that approximately 7.6 million individuals in the UK are affected by heart and circulatory diseases, comprising around 4 million males and 3.6 million females. These diseases account for approximately 27% of all deaths in the UK, resulting in over 170,000 fatalities each year, or roughly 480 deaths daily, which translates to one death every three minutes. Thus, the rising prevalence of heart diseases is propelling the expansion of the paper diagnostics market.
Major companies in the paper diagnostics market are concentrating on creating innovative point-of-care tests to secure a competitive advantage. A point-of-care test is a diagnostic assessment conducted at or near the location of patient care, enabling immediate results and timely clinical decision-making. For example, in August 2023, Mylab Discovery Solutions, an India-based company, introduced two rapid point-of-care tests for detecting dengue infections: the rapid gold test and the high-accuracy dry luminescence assay test. These tests deliver results within 15 to 20 minutes without the requirement for a laboratory setup. They assist in determining the stage and progression of the infection, thereby supporting dengue screening initiatives in resource-constrained areas. The tests can distinguish between IgM and IgG antibodies, providing healthcare professionals with precise tools for timely diagnosis and effective disease management.
In March 2023, Servier, a pharmaceutical group based in France, formed a partnership with QIAGEN to create a companion diagnostic test for identifying IDH1 mutations in patients with acute myeloid leukemia (AML). This collaboration is motivated by crucial phase 3 clinical data from the AGILE study, which highlights the superior outcomes of ivosidenib combined with azacitidine for AML patients harboring IDH1 mutations. QIAGEN is a Germany-based provider of paper diagnostic solutions.
Major companies operating in the paper diagnostics market are Abbott Inc, Arkray Inc, Acon Laboratories Inc, Chembio Diagnostic Systems Inc, Abingdon Health, Micro Essential Laboratory Inc, Paperdrop Diagnostics, Diagnostics for All Inc, Mologic Ltd, BioMedomics Inc, EKF Diagnostics Holdings plc, Sysmex Corporation, Siemens Healthineers AG, BioPorto Diagnostics A/S, NanoEnTek Inc, BiognostiX GmbH, BioDot Inc, BioFluidica Inc, Cytodiagnostics Inc, Biopico Systems Inc.
North America was the largest region in the paper diagnostics market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the paper diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the paper diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the paper diagnostics market by increasing costs of imported reagents, enzymes, specialty papers, and microfluidic components used in diagnostic and monitoring devices. Healthcare systems in North America and Europe are most affected due to reliance on imported consumables, while Asia-Pacific faces higher costs for export-driven diagnostic manufacturing. These tariffs are raising unit prices and impacting large-scale screening programs. At the same time, they are encouraging local production of paper-based diagnostics, regional material sourcing, and innovation in low-cost diagnostic platforms.
The paper diagnostics market research report is one of a series of new reports that provides paper diagnostics market statistics, including paper diagnostics industry global market size, regional shares, competitors with a paper diagnostics market share, detailed paper diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the paper diagnostics industry. This paper diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Paper diagnostics stand as instruments employing cellulosic and paper-based materials to detect and quantify chemicals and bio-molecules affecting health. Widely employed across healthcare domains, including hospitals, medical practices, sports testing arenas, and prenatal clinics, these devices play a crucial role in health assessment.
The realm of paper diagnostics, key classifications include dipsticks, lateral flow assays, and paper-based microfluidics. A urine dipstick test, for instance, involves immersing a specific paper strip into a urine sample for analysis. These devices come in varied types, serving as both monitoring tools and diagnostic aids. Their applications span environmental monitoring, clinical diagnostics, and food quality assessments, catering to end-users such as home healthcare, assisted living facilities, as well as hospitals and clinics.
The paper diagnostics market consists of sales of paper diagnostics for commercial colorimetric tests, and LFA (lateral flow assay) paper-based testing. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The paper diagnostics market size is expected to see rapid growth in the next few years. It will grow to $17.31 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to increasing demand for home-based diagnostics, rising investments in affordable healthcare technologies, expansion of preventive healthcare screening, growing focus on early disease detection, advancements in paper microfluidics technology. Major trends in the forecast period include increasing adoption of rapid point-of-care paper tests, rising demand for low-cost diagnostic solutions, growing use of lateral flow assays, expansion of paper-based microfluidic devices, enhanced focus on disposable and eco-friendly diagnostics.
The rising prevalence of heart diseases is anticipated to drive growth in the paper diagnostics market in the future. Heart disease refers to any condition that affects the cardiovascular system. A sensitive and rapid microfluidic paper-based device (PAD) enables the simultaneous detection of multiple cardiac biomarkers for the early and late diagnosis of acute myocardial infarction. Consequently, the growing incidence of heart diseases is increasing the demand for paper diagnostics. For example, in September 2024, data published by the British Heart Foundation, a UK-based cardiovascular research charity, revealed that approximately 7.6 million individuals in the UK are affected by heart and circulatory diseases, comprising around 4 million males and 3.6 million females. These diseases account for approximately 27% of all deaths in the UK, resulting in over 170,000 fatalities each year, or roughly 480 deaths daily, which translates to one death every three minutes. Thus, the rising prevalence of heart diseases is propelling the expansion of the paper diagnostics market.
Major companies in the paper diagnostics market are concentrating on creating innovative point-of-care tests to secure a competitive advantage. A point-of-care test is a diagnostic assessment conducted at or near the location of patient care, enabling immediate results and timely clinical decision-making. For example, in August 2023, Mylab Discovery Solutions, an India-based company, introduced two rapid point-of-care tests for detecting dengue infections: the rapid gold test and the high-accuracy dry luminescence assay test. These tests deliver results within 15 to 20 minutes without the requirement for a laboratory setup. They assist in determining the stage and progression of the infection, thereby supporting dengue screening initiatives in resource-constrained areas. The tests can distinguish between IgM and IgG antibodies, providing healthcare professionals with precise tools for timely diagnosis and effective disease management.
In March 2023, Servier, a pharmaceutical group based in France, formed a partnership with QIAGEN to create a companion diagnostic test for identifying IDH1 mutations in patients with acute myeloid leukemia (AML). This collaboration is motivated by crucial phase 3 clinical data from the AGILE study, which highlights the superior outcomes of ivosidenib combined with azacitidine for AML patients harboring IDH1 mutations. QIAGEN is a Germany-based provider of paper diagnostic solutions.
Major companies operating in the paper diagnostics market are Abbott Inc, Arkray Inc, Acon Laboratories Inc, Chembio Diagnostic Systems Inc, Abingdon Health, Micro Essential Laboratory Inc, Paperdrop Diagnostics, Diagnostics for All Inc, Mologic Ltd, BioMedomics Inc, EKF Diagnostics Holdings plc, Sysmex Corporation, Siemens Healthineers AG, BioPorto Diagnostics A/S, NanoEnTek Inc, BiognostiX GmbH, BioDot Inc, BioFluidica Inc, Cytodiagnostics Inc, Biopico Systems Inc.
North America was the largest region in the paper diagnostics market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the paper diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the paper diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the paper diagnostics market by increasing costs of imported reagents, enzymes, specialty papers, and microfluidic components used in diagnostic and monitoring devices. Healthcare systems in North America and Europe are most affected due to reliance on imported consumables, while Asia-Pacific faces higher costs for export-driven diagnostic manufacturing. These tariffs are raising unit prices and impacting large-scale screening programs. At the same time, they are encouraging local production of paper-based diagnostics, regional material sourcing, and innovation in low-cost diagnostic platforms.
The paper diagnostics market research report is one of a series of new reports that provides paper diagnostics market statistics, including paper diagnostics industry global market size, regional shares, competitors with a paper diagnostics market share, detailed paper diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the paper diagnostics industry. This paper diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Paper diagnostics stand as instruments employing cellulosic and paper-based materials to detect and quantify chemicals and bio-molecules affecting health. Widely employed across healthcare domains, including hospitals, medical practices, sports testing arenas, and prenatal clinics, these devices play a crucial role in health assessment.
The realm of paper diagnostics, key classifications include dipsticks, lateral flow assays, and paper-based microfluidics. A urine dipstick test, for instance, involves immersing a specific paper strip into a urine sample for analysis. These devices come in varied types, serving as both monitoring tools and diagnostic aids. Their applications span environmental monitoring, clinical diagnostics, and food quality assessments, catering to end-users such as home healthcare, assisted living facilities, as well as hospitals and clinics.
The paper diagnostics market consists of sales of paper diagnostics for commercial colorimetric tests, and LFA (lateral flow assay) paper-based testing. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Paper Diagnostics Market Characteristics
3. Paper Diagnostics Market Supply Chain Analysis
4. Global Paper Diagnostics Market Trends and Strategies
5. Paper Diagnostics Market Analysis of End Use Industries
7. Global Paper Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Paper Diagnostics Total Addressable Market (TAM) Analysis for the Market
9. Paper Diagnostics Market Segmentation
10. Paper Diagnostics Market Regional and Country Analysis
11. Asia-Pacific Paper Diagnostics Market
12. China Paper Diagnostics Market
13. India Paper Diagnostics Market
14. Japan Paper Diagnostics Market
15. Australia Paper Diagnostics Market
16. Indonesia Paper Diagnostics Market
17. South Korea Paper Diagnostics Market
18. Taiwan Paper Diagnostics Market
19. South East Asia Paper Diagnostics Market
20. Western Europe Paper Diagnostics Market
21. UK Paper Diagnostics Market
22. Germany Paper Diagnostics Market
23. France Paper Diagnostics Market
24. Italy Paper Diagnostics Market
25. Spain Paper Diagnostics Market
26. Eastern Europe Paper Diagnostics Market
27. Russia Paper Diagnostics Market
28. North America Paper Diagnostics Market
29. USA Paper Diagnostics Market
30. Canada Paper Diagnostics Market
31. South America Paper Diagnostics Market
32. Brazil Paper Diagnostics Market
33. Middle East Paper Diagnostics Market
34. Africa Paper Diagnostics Market
36. Paper Diagnostics Market Competitive Landscape and Company Profiles
37. Paper Diagnostics Market Other Major and Innovative Companies
40. Paper Diagnostics Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Paper Diagnostics Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses paper diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for paper diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The paper diagnostics market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Dipsticks; Lateral Flow Assays: Paper-Based Microfluidics2) By Application: Environmental Monitoring; Clinical Diagnostics; Food Quality Testing
3) By End-User: Home Healthcare; Assisted Living Healthcare Facilities; Hospital And Clinics
Subsegments:
1) By Dipsticks: Urinalysis Dipsticks; Blood Glucose Dipsticks; Pregnancy Test Dipsticks; Drug Test Dipsticks2) By Lateral Flow Assays: Point-Of-Care Testing (POCT) Assays; Rapid Infectious Disease Tests; Cardiovascular Marker Tests; Allergy Tests
3) By Paper-Based Microfluidics: Integrated Microfluidic Devices; Environmental Testing Applications; Food Safety Testing Applications
Companies Mentioned: Abbott Inc; Arkray Inc; Acon Laboratories Inc; Chembio Diagnostic Systems Inc; Abingdon Health; Micro Essential Laboratory Inc; Paperdrop Diagnostics; Diagnostics for All Inc; Mologic Ltd; BioMedomics Inc; EKF Diagnostics Holdings plc; Sysmex Corporation; Siemens Healthineers AG; BioPorto Diagnostics A/S; NanoEnTek Inc; BiognostiX GmbH; BioDot Inc; BioFluidica Inc; Cytodiagnostics Inc; Biopico Systems Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Paper Diagnostics market report include:- Abbott Inc
- Arkray Inc
- Acon Laboratories Inc
- Chembio Diagnostic Systems Inc
- Abingdon Health
- Micro Essential Laboratory Inc
- Paperdrop Diagnostics
- Diagnostics for All Inc
- Mologic Ltd
- BioMedomics Inc
- EKF Diagnostics Holdings plc
- Sysmex Corporation
- Siemens Healthineers AG
- BioPorto Diagnostics A/S
- NanoEnTek Inc
- BiognostiX GmbH
- BioDot Inc
- BioFluidica Inc
- Cytodiagnostics Inc
- Biopico Systems Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 11.62 Billion |
| Forecasted Market Value ( USD | $ 17.31 Billion |
| Compound Annual Growth Rate | 10.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
